- 3 de janeiro de 2017
- Posted by: Assessoria Imprensa
- Category: Destaques, Lançamentos, Noticias

A Anvisa publicou nesta segunda-feira, 2 de janeiro, o registro do medicamentos Nuwiq que tem como substância ativa o fator de coagulação VIII recombinante humano (alfasimoctocogue). O medicamento, registrado como produto biológico novo, substitui o fator VIII no corpo humano e é utilizado para o tratamento e prevenção de hemorragias em pacientes com hemofilia A.
O fator VIII está presente no sangue e é necessário para formar coágulos e estancar sangramentos de forma natural no organismo. Em pessoas com hemofilia A, a ausência desta substância faz com que o doente possa ter sangramentos nas articulações e mesmo intracranianos.
O Nuwiq (alfasimoctocogue) pode ser utilizado em todas as faixas etárias e foi aprovado com a indicação para “o tratamento e profilaxia de sangramentos em pacientes com hemofilia A (deficiência congênita do fator VIII de coagulação)”. Apesar de existirem outras substitutos ao fator VIII no mercado, o Nuwiq foi considerado novo por ter um menor potencial de provocar imunogenicidade.
Com informações Ascom/Anvisa
The other day, while I was at work, my cousin stole my apple ipad aand tested to
ssee iif it can survive a 30 foot drop, just so she ccan be a youtube sensation. My apple ipad
is now broken annd she has 83 views. I know this is entirely
off topic but I had to share it with someone!
Great article. I will bbe experiencing many of these issues as
well..
Hello to all, it’s really a nice for me to go too see this web page, it
includes precious Information.
Withh hagin so much content do you ever run into any problems
of plagorism or copyright violation? My site has a lot oof completely unique
content I’ve either created myself orr outsourced but iit seems a lott of
it is popping it up all over the internet without my permission. Do
youu know any techniques to heop prevent content from being stolen? I’d really appreciate it.
Wow, this article iss pleasant, my sister is analyzing these things, thus
I am going to infoorm her.
Hi there everyone, it’s my first visit at this web page, annd paragraph is actually fruitful for me, keep up posting such articles or reviews.
I’m more than happy to find this web site. I needd to to thank you for your time for this particularly fantastic read!!
I definitely enjoyed every bit of iit and i also have you saved to fav to
see neww thigs in your blog.
Hello everyone, it’s my first go to see at this web site, and paragrapph is genuinely fruitful inn support of me, keep up posting such posts.